2-Cyanoisonicotinohydrazide

Catalog No. :
ACCVRG815
CAS No. :
135048-32-7
Molecular Formula :
C7H6N4O
Molecular Weight :
162.15

IUPAC Name:2-cyanoisonicotinohydrazide

2-Cyanoisonicotinohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$82.00Login to see priceIn stockIn stock
25g95%$271.00Login to see priceIn stockIn stock
100g95%$976.00Login to see priceIn stockInquiry
500g95%$3689.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Cyanoisonicotinohydrazide
IUPAC Name2-cyanoisonicotinohydrazide
MDL No.MFCD23132274
Molecular FormulaC7H6N4O
Molecular Weight162.15
SMILESO=C(NN)C1=CC=NC(C#N)=C1
InChI KeyPPDYFTPCRSZNRD-UHFFFAOYSA-N
Synonym4-Pyridinecarboxylicacid,2-cyano-,hydrazide(9CI);2-cyanoisonicotinic acid hydrazide;2-Cyanoisonicotinohydrazide;4-Pyridinecarboxylicacid,2-cyano-,hydrazide;2-Cyano-4-pyridinecarboxylic acid hydrazide;Topiroxostat impurity M;Topirastat impurity 18;2-cyanoisoniazide
CAS No.135048-32-7
PubChem CID45084626

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCVRG815 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCEIH308 route compound structure diagram
    ACCEIH30894413-64-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCVRG815 route product structure diagram
    ACCVRG815135048-32-7 In Stock
Inquiry

2. ACCVRG815 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGXKT459 route compound structure diagram
    ACGXKT45958481-14-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCVRG815 route product structure diagram
    ACCVRG815135048-32-7 In Stock
Inquiry

Comments (0)